Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.1

(0.88%)

FLWS

$3.61

(1.4%)

ACCO

$4.23

(0.48%)

ARLP

$24.06

(-1.72%)

AUIAF

$0.13

(-5.29%)

AZZ

$155.9

(-0.47%)

BTBT

$1.88

(-5.63%)

BTM

$0.49

(0%)

CVKD

$3.06

(0.49%)

LCE:CA

$0.27

(1.89%)

COCP

$1.01

(-0.49%)

CDRO

$9.52

(-1.24%)

CVGI

$4.73

(4.88%)

LODE

$4.21

(-3.11%)

CMTL

$2.09

(0.97%)

CNDT

$1.31

(-0.76%)

CXW

$30.47

(-0.97%)

CMLS

$0.01

(0%)

DRCT

$2.58

(-2.83%)

DLHC

$5.38

(2.38%)

SSP

$2.85

(-1.9%)

ELDN

$3.85

(1.72%)

EVC

$12.9

(7.23%)

EDRY

$22.19

(0.82%)

ESEA

$66.13

(-0.33%)

FAT

$0.16

(0%)

RAIL

$9.61

(-5.78%)

GDEV

$12.14

(1.17%)

GOVX

$1.31

(-0.77%)

GOCO

(0%)

GHM

$120.79

(-0.72%)

GLDD

$17

(0%)

GYRE

$7.58

(-1.88%)

HMENF

$1.72

(0%)

III

$4.14

(-1.43%)

IPOOF

$10.14

(-0.02%)

KELYA

$12.81

(0.63%)

KTOS

$47.51

(0.65%)

LUCK

$7.83

(-0.82%)

MAIA

$1.47

(3.9%)

MGROF

$0.28

(-4.7%)

NTRB

$3.39

(10.78%)

OCGN

$1.67

(11%)

PERF

$1.66

(-0.3%)

QMCI

$0.15

(0%)

RGP

$4.39

(7.86%)

SGA

$8.71

(0.23%)

SHWZ

(0%)

SHIP

$13.84

(-0.86%)

SLQT

$0.82

(-0.15%)

SKYX

$1.04

(9.91%)

SNAL

$0.63

(3.78%)

GEO

$29.71

(-2.14%)

ODP

$28

(0%)

TNXP

$12.81

(-3.06%)

TSQ

$6.7

(-1.9%)

TZOO

$11.92

(6.81%)

UNCY

$7.88

(10.52%)

VVX

$72.53

(0.06%)

VNCE

$7.52

(-3.09%)

XELB

$1.75

(-1.96%)

ZOMDF

$0.1

(0.88%)

FLWS

$3.61

(1.4%)

channelchek-in

‌

6/29/2026

Zymeworks Moves to Acquire Theravance Biopharma in $929 Million Deal

Vancouver-based Zymeworks (Nasdaq: ZYME) announced this morning it has signed a definitive agreement to acquire Theravance Biopharma (Nasdaq: TBPH) for $17.00 per share in cash, a deal valued at roughly $929 million. The transaction adds YUPELRI® (revefenacin), the only nebulized once-daily LAMA approved for COPD maintenance therapy, to Zymeworks’ growing portfolio of partnered commercial assets.

3 min read